Moussaoui, S <br/><br/>
The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease.  [electronic resource] 

 -  Experimental neurology  Dec 2000 
 - 235-45 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0014-4886 
<br/><br/><label>Standard No.: </label>10.1006/exnr.2000.7516  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenylpyridinium--pharmacokinetics<br/>Animals<br/>Antioxidants--pharmacology<br/>Azoles--pharmacology<br/>Behavior, Animal--drug effects<br/>Blood Proteins--pharmacology<br/>Callithrix<br/>Caudate Nucleus--metabolism<br/>Disease Models, Animal<br/>Female<br/>Free Radicals--metabolism<br/>Glutathione Peroxidase--metabolism<br/>Herbicides--pharmacokinetics<br/>Isoindoles<br/>Locomotion--drug effects<br/>Male<br/>Mitochondria--drug effects<br/>Molecular Mimicry<br/>Neurons--cytology<br/>Neuroprotective Agents--pharmacology<br/>Organoselenium Compounds--pharmacology<br/>PC12 Cells<br/>Parkinsonian Disorders--drug therapy<br/>Rats<br/>Rats, Sprague-Dawley<br/>Substantia Nigra--metabolism<br/>Tritium